skip to contents
Dr. Ho Jin Kim is a consultant neurologist and principal scientist at the Research Institute and Hospital of National Cancer Center, Goyang Korea. He is also professor of Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science & Policy.
Dr. Kim received his medical degree from Seoul National University where he also completed his residency training in neurology and clinical fellowship in multiple sclerosis (MS) and neuromuscular disease. Dr. Kim went on to pursue his academic research interest as a research fellow in neuroimmunology at the University of Southern California, Keck School of Medicine, Los Angeles, California, USA for a year. Then he spent four years as a senior fellow and staff researcher in MS and neuroimmunology at the Montreal Neurological Institute of McGill University, Montreal, Quebec, Canada.
His major research interests lie in studying the development and application of biological assays to monitor the disease process and evaluate the response to novel therapeutics. His other research interests are in studying differences among various autoimmune inflammatory diseases of CNS including MS, neuromyelitis optica spectrum disorder and MOG-IgG associated disease in both clinical and radiological features as well as underlying pathogenesis.
Dr. Kim is widely published and a member of many prominent professional societies and associations including the American Academy of Neurology, European Neurological Society, The Federation of Clinical Immunology Societies, the Korean Neurological Association, and the Korean Society of Multiple Sclerosis. He is a vicepresident of PACTRIMS and a member of central organizing committee and scientific committee of PACTRIMS. He also serves as a co-editor for Multiple Sclerosis Journal – Experimental, Translational and Clinical and an associated editor for Journal of Clinical Neurology.